ANAPHYLACTOID REACTION TO A SMALL DOSE OF d-TUBOCURARINE

InPharma ◽  
1979 ◽  
Vol 212 (1) ◽  
pp. 7-7
Keyword(s):  
Small Dose ◽  
Anaphylactoid Reaction

SENSITIZATION BY INSULIN TO THE DEXTRAN "ANAPHYLACTOID" REACTION

1957 ◽  
Vol 35 (1) ◽  
pp. 251-256 ◽  
Author(s):  
V. W. Adamkiewicz ◽  
Y. Langlois
Keyword(s):  
Small Dose ◽  
Subcutaneous Injection ◽  
Anaphylactoid Reaction ◽  
Crystalline Insulin ◽  
Single Subcutaneous Injection ◽  
Small Doses

A single subcutaneous injection of crystalline insulin (20 units) sensitizes considerably the rats to the dextran "anaphylactoid" reaction. This is a type of acute serous inflammation. Insulin precipitates the reaction after a very small dose of dextran (0.05–0.01 ml., 6% solution) has been injected into a "shock organ". Without insulin, such small doses of dextran are quite ineffective. Insulin also precipitates the reaction when dextran (1.0 ml., 6% solution) is injected peripherally on the back. In this site and at this dose, it rarely produces the reaction in normal rats. The sensitization manifests itself despite a cortisone pretreatment.

SENSITIZATION BY INSULIN TO THE DEXTRAN "ANAPHYLACTOID" REACTION

1957 ◽  
Vol 35 (4) ◽  
pp. 251-256 ◽  
Author(s):  
V. W. Adamkiewicz ◽  
Y. Langlois
Keyword(s):  
Small Dose ◽  
Subcutaneous Injection ◽  
Anaphylactoid Reaction ◽  
Crystalline Insulin ◽  
Single Subcutaneous Injection ◽  
Small Doses

A single subcutaneous injection of crystalline insulin (20 units) sensitizes considerably the rats to the dextran "anaphylactoid" reaction. This is a type of acute serous inflammation. Insulin precipitates the reaction after a very small dose of dextran (0.05–0.01 ml., 6% solution) has been injected into a "shock organ". Without insulin, such small doses of dextran are quite ineffective. Insulin also precipitates the reaction when dextran (1.0 ml., 6% solution) is injected peripherally on the back. In this site and at this dose, it rarely produces the reaction in normal rats. The sensitization manifests itself despite a cortisone pretreatment.

A Case of Malignant Lymphoma that Healed Completely after Oral Administrations of 4-Hydroxybenzaldehyde

2018 ◽  
Vol 1 (1) ◽  
pp. 01-02
Keyword(s):  
Cancer Patient ◽  
Malignant Lymphoma ◽  
Large Dose ◽  
Side Effect ◽  
Small Dose ◽  
Severe Hemorrhage ◽  
Tumor Agent

In 1969, Mutsuyuki Kochi [1, 2] developed 4-Hydroxybenzaldehyde for use as a novel anti-tumor agent without side effect and patent it. Accordingly, this medicine is capable of preventing carcinogenesis when used in sufficient quantity. To treat advanced cancers, an oncologist should start with giving the cancer patient a small dose of 4-Hydroxybenzaldehyde to avoid the possible severe hemorrhage of a tumor caused by excessive necrosis. Therefore, it has useful applications in treating lymphomas and leukemias. Consequently, those who have these diseases can receive a considerably large dose of the medicine.

scholarly journals Prevention of Fatal Pulmonary Thromboembolism by Heparin Prophylaxis after Surgery for Hip Fractures

1977 ◽  
Author(s):  
J.G. Sharnoff
Keyword(s):  
Small Dose ◽  
Pulmonary Thromboembolism ◽  
Fatal Pulmonary Embolism ◽  
Coagulation Test ◽  
Coagulation Time ◽  
Acute Fracture ◽  
Dose Heparin ◽  
Time Test ◽  
Heparin Prophylaxis ◽  
Blood Coagulation Test

From 1960 through 1975, 337 patients with surgically treated acute fracture of the hip received subcutaneously administered aqueous heparin sodium to prevent thromboembolic episodes. Four hundred and three patients received no heparin. Their incidence of fatal pulmonary embolism was 3.5 percent. Ninety-five patients receiving the original “small dose” heparin regimen from August 1960 to November 1967 had a 4.2 percent incidence of fatal thromboembolism. These had been administered heparin 8-10 hours or less before surgery. Beginning November 1967 the “small dose” heparin schedule was altered in hip fracture patients to start heparin prophylaxis immediately following hospital admission. One hundred and forty-seven patients treated with the latter schedule had 0.0 percent fatal thromboembolism with the dose modified according to a coagulation time test. The patients received 2,500 units on admission and every 6 hours until the day before operation. Then they were given 5,000 to 10,000 units. 8 to 10 hours before surgery and 2,500 units every 6 hours after surgery until they were fully mobilized. The altered “small dose” heparin regimen adequately monitored by the blood coagulation test, the Dale and Laidlaw Coagulometer, proved highly effective as measured by fatality rates.

Apparent anaphylactoid reaction after treatment with a single dose of telithromycin

2007 ◽  
Vol 98 (1) ◽  
pp. 89-91 ◽  
Author(s):  
Michelle M. Bottenberg ◽  
Geoffrey C. Wall ◽  
Greg A. Hicklin
Keyword(s):  
Single Dose ◽  
Anaphylactoid Reaction

Subarachnoid Small-Dose Bupivacaine Versus Lidocaine for Cervical Cerclage

2003 ◽  
pp. 56-61 ◽  
Author(s):  
Yaakov Beilin ◽  
Jeffrey Zahn ◽  
Sharon Abramovitz ◽  
Howard H. Bernstein ◽  
Sabera Hossain ◽  
...  
Keyword(s):  
Small Dose ◽  
Cervical Cerclage
Sign in / Sign up

Export Citation Format

Share Document